NFKB1 and COVID-19: A disrupted NF-κB pathway is a hallmark of chronic inflammatory diseases18, which suggests that NEMO cleavage by 3CLpro and the downstream dysregulation of NF-κB could contribute to the enhanced inflammatory response observed in COVID-19 patients15.